CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 161 filers reported holding CLOVIS ONCOLOGY INC in Q3 2019. The put-call ratio across all filers is 1.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $2,000 | 0.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $2,000 | -60.0% | 300 | -40.0% | 0.00% | 0.0% |
| Q4 2019 | $5,000 | +150.0% | 500 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $2,000 | -80.0% | 500 | -28.6% | 0.00% | -66.7% |
| Q2 2019 | $10,000 | -41.2% | 700 | 0.0% | 0.00% | -50.0% |
| Q1 2019 | $17,000 | +30.8% | 700 | 0.0% | 0.01% | +50.0% |
| Q4 2018 | $13,000 | -43.5% | 700 | -12.5% | 0.00% | -33.3% |
| Q3 2018 | $23,000 | -36.1% | 800 | 0.0% | 0.01% | -40.0% |
| Q2 2018 | $36,000 | -25.0% | 800 | -11.1% | 0.01% | -28.6% |
| Q1 2018 | $48,000 | – | 900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |